Fig. S1 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijia Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406178.v1

2023-01-01

Abstract:PAFR positively correlates with the progression of various cancers.

What problem does this paper attempt to address?

Fig. S11 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijia Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406172

2023-01-01

Abstract:PAF/PAFR axis enhanced the strength and duration of Stat3 activation.
Fig. S4 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijie Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406151

2023-01-01

Abstract:Effects of PAF/PAFR axis on growth and invasion of Calu-3 and H226 cells in vitro.
Fig. S12 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijie Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406169.v1

2023-01-01

Abstract:PAFR expression was associated with pSrc, pJAK2, pStat3, or IL-6 expression in 90 primary human NSCLC specimens.
Fig. S7 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijia Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406142

2023-01-01

Abstract:Effects of PAF/PAFR axis on EMT in Calu-3 and H226 cells.
Fig. S13 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijia Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406166.v1

2023-01-01

Abstract:Effects of PAFR depletion on EMT and Stat3 pathway of NSCLC cells in vivo.
Fig. S15 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijia Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406160

2023-01-01

Abstract:Schematic diagram of the mechanism underlying PAFR-activated Stat3 in the EMT and metastasis of NSCLC.
Fig. S5 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijie Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406148.v1

2023-01-01

Abstract:Effects of PAFR inhibitor-WEB2086 on growth and invasion of A549 and H460 cells in vitro.
Fig. S9 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijia Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406136

2023-01-01

Abstract:Evaluating the effects of Stat3 shRNA, or it in the presence of 100 nM PAF on the invasion of A549 and H460 cells using transwell invasion assay.
Fig. S14 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijia Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406163

2023-01-01

Abstract:Statistical analyses of PAFR, E-cadherin, N-cadherin, vimentin, snail, Zeb-1, pSrc, pJAK2, pStat3, or IL-6 in A549 and H460 tumors stably expressing shPAFR or their respectively control shRNA.
Supplementary Table 5 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijia Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406121

2023-01-01

Abstract:overexpression of PAFR in gastric cancer
supplementary Table 7 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijie Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406115

2023-01-01

Abstract:Correlation between the clinicopathologic features and expression of PAFR in colon cancer
Supplementary Table 2 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijie Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406130.v1

2023-01-01

Abstract:Correlation between the clinicopathologic features and expression of PAFR in NSCLC
Fig. S10 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijia Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406175

2023-01-01

Abstract:Evaluating the effects of shRNA vector, PAFR shRNA, Stat3 shRNA, or these shRNAs in the presence of 100 nM PAF on the mRNA level of IL-6 in A549 and H460 cells.
Aberrantly Expressed Fra-1 by Il-6/Stat3 Transactivation Promotes Colorectal Cancer Aggressiveness Through Epithelial-Mesenchymal Transition

Hong Liu,Guoping Ren,Tingyang Wang,Yuexia Chen,Chaoju Gong,Yanfeng Bai,Bo Wang,Hongyan Qi,Jing Shen,Lijun Zhu,Cheng Qian,Maode lai,Jimin Shao

DOI: https://doi.org/10.1093/carcin/bgv017

2015-01-01

Carcinogenesis

Abstract:The pro-inflammatory cytokine interleukin-6 (IL-6) in tumor microenvironment has been suggested to promote development and progression of colorectal cancer (CRC). However, the underlying molecular mechanisms remain elusive. In this study, we demonstrate that fos-related antigen-1 (Fra-1) plays a critical role in IL-6 induced CRC aggressiveness and epithelial-mesenchymal transition (EMT). In CRC cell lines, the expression of Fra-1 gene was found significantly upregulated during IL-6-driven EMT process. The Fra-1 induction occurred at transcriptional level in a manner dependent on signal transducer and activator of transcription 3 (STAT3), during which both phosphorylated and acetylated post-translational modifications were required for STAT3 activation to directly bind to the Fra-1 promoter. Importantly, RNA interference-based attenuation of either STAT3 or Fra-1 prevented IL-6-induced EMT, cell migration and invasion, whereas ectopic expression of Fra-1 markedly reversed the STAT3-knockdown effect and enhanced CRC cell aggressiveness by regulating the expression of EMT-promoting factors (ZEB1, Snail, Slug, MMP-2 and MMP-9). Furthermore, Fra-1 levels were positively correlated with the local invasion depth as well as lymph node and liver metastasis in a total of 229 CRC patients. Intense immunohistochemical staining of Fra-1 was observed at the tumor marginal area adjacent to inflammatory cells and in parallel with IL-6 secretion and STAT3 activation in CRC tissues. Together, this study proposes the existence of an aberrant IL-6/STAT3/Fra-1 signaling axis leading to CRC aggressiveness through EMT induction, which suggests novel therapeutic opportunities for the malignant disease.
JAK/STAT3 Signaling is Required for TGF-β-induced Epithelial-Mesenchymal Transition in Lung Cancer Cells.

Reng-Yun Liu,Yuanyuan Zeng,Zhe Lei,Longqiang Wang,Haiping Yang,Zeyi Liu,Jun Zhao,Hong-Tao Zhang

DOI: https://doi.org/10.3892/ijo.2014.2310

2014-01-01

International Journal of Oncology

Abstract:Epithelial-mesenchymal transition (EMT), a key step in the early stages of cancer metastasis, is orchestrated by several signaling pathways, including IL-6/JAK/STAT3 and TGF-β/Smad signaling. However, an association between the two signaling pathways during the EMT process is largely unknown. Here, we focused on lung cancer and demonstrated that TGF-β1 induced the phosphorylation of Smad3 (p-Smad3), upregulation of Snail, a fibroblast-like morphology, and downregulation of E-cadherin as well as upregulation of vimentin in lung cancer cell lines. SIS3 (an inhibitor of Smad3) suppressed TGF-β1-induced activation of Smad3, upregulation of Snail and the EMT process. Importantly, the JAK2/STAT3-specific inhibitor AG490 blocked Stat3 phosphorylation, resulting in attenuated levels of TGF-β1-induced p-Smad3, Snail, MMP2, and Smad-mediated PAI-1 promoter reporter gene activity in A549 and H1650 cells. Subsequently, AG490 inhibited TGF-β-induced cell migration and invasion. Moreover, exogenous IL-6 treatment stimulated Stat3 activation, enhanced TGF-β-induced expression of p-Smad3 and Snail, aggravated the EMT process, and increased lung cancer cell migration and invasion induced by TGF-β1. Our findings show that the JAK/STAT3 pathway is required for TGF-β-induced EMT and cancer cell migration and invasion via upregulation of the expression of p-Smad3 and Snail, and the IL-6/JAK/STAT3 and TGF-β/Smad signaling synergistically enhance EMT in lung carcinomas. The present study suggests a novel rationale for inhibiting cancer metastasis using anti-IL-6/JAK/STAT3 and anti-TGF-β/Smad therapeutic strategies.
FSCN1 Induced PTPRF-dependent Tumor Microenvironment Inflammatory Reprogramming Promotes Lung Adenocarcinoma Progression Via Regulating Macrophagic Glycolysis

Yiwei Huang,Guangyao Shan,Yanjun Yi,Jiaqi Liang,Zhengyang Hu,Guoshu Bi,Zhencong Chen,Junjie Xi,Di Ge,Qun Wang,Lijie Tan,Wei Jiang,Cheng Zhan

DOI: https://doi.org/10.1007/s13402-022-00726-0

IF: 7.051

2022-01-01

Cellular Oncology

Abstract:Purpose Macrophages (MΦs) play a dual role in the promotion and suppression of lung adenocarcinoma (LUAD), the function of which is influenced by the metabolic status. The role of protein tyrosine phosphatase receptor type F (PTPRF) in cancer has not been elucidated, and its role in MΦs remains to be seen. Methods The Seahorse XFe 96 Cell Flow Analyzer detected glucose metabolism in tumor cells and macrophages. The expressions of FSCN1, M-CSF, IL4, PTPRF and IGF1 in macrophages were detected by Western blotting and qRT-PCR. Binding of FSCN1 and IGF1R was detected by co-immunoprecipitation. The tumor status in animals was observed using the IVIS Lumina III imaging system. Results We found that Fascin Actin-Bundling Protein 1 (FSCN1) activates the PI3K-AKT and JAK-STAT signaling pathways in LUAD cells via binding to IGF-1R, thereby promoting the secretion of cytokines such as IL4 and M-CSF. IL4 and M-CSF promote the expression of PTPRF in MΦs, leading to M2 polarization of MΦs by increasing glucose intake and lactate production. In return, M2-type MΦs act on LUAD cells by secreting cytokines such as IGF-1, CCL2, and IL10, which ultimately promote tumor progression. In vivo experiments proved that the knockdown of FSCN1 in A549 cells and PTPRF in MΦs greatly reduced LUAD proliferative and metastatic capacity, which was consistent with the in vitro findings. Conclusions This study investigated the reprogramming effects of FSCN1 and PTPRF on inflammatory cytokines in the LUAD microenvironment, revealing potential mechanisms by which FSCN1 and PTPRF promote tumor progression and providing a new experimental basis for LUAD treatment.
PAFR/Stat3 Axis Maintains the Symbiotic Ecosystem Between Tumor and Stroma to Facilitate Tumor Malignancy

Di Zhao,Jing Zhang,Lingyuan Zhang,Qingnan Wu,Yan Wang,Weimin Zhang,Yuanfan Xiao,Jie Chen,Qimin Zhan

DOI: https://doi.org/10.1016/j.apsb.2022.08.014

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:Stroma surrounding the tumor cells plays crucial roles for tumor progression. However, little is known about the factors that maintain the symbiosis between stroma and tumor cells. In this study, we found that the transcriptional regulator-signal transducer and activator of transcription 3（Stat3） was frequently activated in cancer-associated fibroblasts（CAFs）, which was a potent facilitator of tumor malignancy, and formed forward feedback loop with platelet-activating factor receptor（PAFR） both in CAFs and tumor cells. Importantly, PAFR/Stat3 axis connected intercellular signaling crosstalk between CAFs and cancer cells and drove mutual transcriptional programming of these two types of cells. Two central Stat3-related cytokine signaling molecules-interleukin 6（IL-6） and IL-11 played the critical role in the process of PAFR/Stat3 axis-mediated communication between tumor and CAFs. Pharmacological inhibition of PAFR and Stat3 activities effectively reduced tumor progression using CAFs/tumor co-culture xenograft model. Our study reveals that PAFR/Stat3 axis enhances the interaction between tumor and its associated stroma and suggests that targeting this axis can be an effective therapeutic strategy against tumor malignancy.
Supplementary Figure from TGF-β-Induced FLRT3 Attenuation is Essential for Cancer-Associated Fibroblast–Mediated Epithelial–Mesenchymal Transition in Colorectal Cancer

Mengdi Yang,Dan Li,Zhiyuan Jiang,Changcan Li,Suyuan Ji,Jing Sun,Yujie Chang,Shunyi Ruan,Zhiyu Wang,Rui Liang,Xueyu Dai,Bin Li,Hui Zhao

DOI: https://doi.org/10.1158/1541-7786.22527761.v1

2023-01-01

Abstract:Supplementary Figure from TGF-β-Induced FLRT3 Attenuation Is Essential for Cancer-Associated Fibroblast–Mediated Epithelial–Mesenchymal Transition in Colorectal Cancer
Supplementary Figure 1 from EIF4A3 Acts on the PI3K–AKT–ERK1/2–P70S6K Pathway Through FLOT1 to Influence the Development of Lung Adenocarcinoma

Wenhao Yu,Jinghui Liang,Tao Fang,Jin Jiang,Renchang Zhao,Rongyang Li,Jingyi Han,Hui Tian

DOI: https://doi.org/10.1158/1541-7786.22658510

2023-01-01

Abstract:EIF4A3 promotes the proliferation and migration of LUAD cells in vitro.

Fig. S1 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Fig. S11 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Fig. S4 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Fig. S12 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Fig. S7 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Fig. S13 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Fig. S15 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Fig. S5 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Fig. S9 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Fig. S14 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Supplementary Table 5 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

supplementary Table 7 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Supplementary Table 2 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Fig. S10 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Aberrantly Expressed Fra-1 by Il-6/Stat3 Transactivation Promotes Colorectal Cancer Aggressiveness Through Epithelial-Mesenchymal Transition

JAK/STAT3 Signaling is Required for TGF-β-induced Epithelial-Mesenchymal Transition in Lung Cancer Cells.

FSCN1 Induced PTPRF-dependent Tumor Microenvironment Inflammatory Reprogramming Promotes Lung Adenocarcinoma Progression Via Regulating Macrophagic Glycolysis

PAFR/Stat3 Axis Maintains the Symbiotic Ecosystem Between Tumor and Stroma to Facilitate Tumor Malignancy

Supplementary Figure from TGF-β-Induced FLRT3 Attenuation is Essential for Cancer-Associated Fibroblast–Mediated Epithelial–Mesenchymal Transition in Colorectal Cancer

Supplementary Figure 1 from EIF4A3 Acts on the PI3K–AKT–ERK1/2–P70S6K Pathway Through FLOT1 to Influence the Development of Lung Adenocarcinoma